2,5-dimethoxy-4-bromoamphetamine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glennon, RA | 1 |
Appel, NM; De Souza, EB; Glennon, RA; Leonhardt, S; Teitler, M | 1 |
Dimpfel, W; Nichols, DE; Spüler, M | 1 |
Cuddy, ML | 1 |
Braida, D; Ponzoni, L; Sala, M | 1 |
Lopez-Vallejo, F; Mariño Gaviria, DJ; Mendoza-Valencia, CY; Patiño Reyes, N; Sarmiento Gutiérrez, ÁE; Trespalacios Rodríguez, D | 1 |
1 review(s) available for 2,5-dimethoxy-4-bromoamphetamine and n-methyl-3,4-methylenedioxyamphetamine
Article | Year |
---|---|
Common drugs of abuse--Part II.
Topics: 4-Butyrolactone; Catha; Designer Drugs; Dibenzothiazepines; Diterpenes; Diterpenes, Clerodane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug and Narcotic Control; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Phenylpropanolamine; Piperazines; Psilocybin; Quetiapine Fumarate; Sodium Oxybate; Substance-Related Disorders; United States | 2004 |
5 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and n-methyl-3,4-methylenedioxyamphetamine
Article | Year |
---|---|
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
Receptor pharmacology of MDMA and related hallucinogens.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Binding, Competitive; Brain; Cell Membrane; Cerebral Cortex; Designer Drugs; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Ketanserin; Kinetics; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1990 |
Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain; Central Nervous System Stimulants; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electroencephalography; Evoked Potentials; Hallucinogens; Injections, Intraperitoneal; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred F344; Telemetry | 1989 |
Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors.
Topics: Amphetamines; Animals; Behavior, Animal; Conditioning, Psychological; DOM 2,5-Dimethoxy-4-Methylamphetamine; Female; Hallucinogens; Male; N-Methyl-3,4-methylenedioxyamphetamine; Receptors, Serotonin, 5-HT2; Reinforcement, Psychology; Reward; Ritanserin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists; Zebrafish | 2016 |
Mix of new substances psychoactive, NPS, found in blotters sold in two Colombian cities.
Topics: Administration, Sublingual; Colombia; Designer Drugs; Dimethoxyphenylethylamine; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug Contamination; Drug Trafficking; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Paper; Substance-Related Disorders | 2019 |